
EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
Dr Shroff, GP in Nottingham, demonstrates a punch biopsy.
Dr Shroff, GP in Nottingham, demonstrates a punch biopsy.
Video created by

